glp-1 market forecast Glucagon Like Peptide-1 (GLP-1) Agonists Report New Demand in an Old

ONeill, C

According to research organization RAND, nearly 12% of Americans have tried drugs like Ozempic (semaglutide) or Zepbound (tirzepatide), and notably, yet another 14% are interested in procuring their own prescription for a GLP-1 medication in the future

Related Reading Hims Subscription Noom Subscription Hers Subscription Zepbound Subscription Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims

Related compounds and next-generation GLP-1 agonists The GLP-1 agonist landscape is evolving rapidly

You can also choose from four great flavors